Clinical trial
Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma
NCT05307289 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 25, 2022
- Completion date
- October 25, 2028
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
melanoma (skin)